Answers are grounded in this paper and cite their sources.
The evaluation of health outcomes requires indicators that go beyond the isolated counting of procedures, disease cases, and deaths, incorporating both the quality and duration of life, as well as the losses resulting from disabling conditions. In this context, the Quality-Adjusted Life Years (QALY) and Disability-Adjusted Life Years (DALY) indicators offer distinct and potentially complementary perspectives. QALY combines the quantity and quality of life into a measure that expresses the gains associated with health interventions, whereas DALY estimates the burden of disease by adding the years of life lost due to premature mortality to the years lived with disability. This article aims to discuss the conceptual and methodological foundations of these indicators, compare their characteristics, and examine their contributions to health technology assessment, priority setting, and resource allocation in health systems. This is a theoretical study with a qualitative approach, conducted through a narrative literature review and documentary analysis. The analysis shows that, although based on different perspectives—health gains and health losses—QALY and DALY can broaden the understanding of health outcomes and support management decisions. However, their use requires careful consideration of methodological choices, the valuation of health states, social inequalities, and the ethical principles that should guide public policies.
No takes yet. Share an insight, caveat, or question.
Orfale et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: